Robert Weinstein to Ciprofloxacin
This is a "connection" page, showing publications Robert Weinstein has written about Ciprofloxacin.
Connection Strength
0.299
-
Multicenter, randomized trial of ciprofloxacin plus azlocillin versus ceftazidime plus amikacin for empiric treatment of febrile neutropenic patients. Am J Med. 1989 Nov 30; 87(5A):278S-282S.
Score: 0.091
-
In vitro susceptibility of nosocomial Pseudomonas aeruginosa, enterobacteriaceae, and staphylococci to ciprofloxacin and ten other broad-spectrum antibiotics. Chemioterapia. 1987 Oct; 6(5):315-8.
Score: 0.078
-
Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use. JAMA. 2003 Feb 19; 289(7):885-8.
Score: 0.057
-
Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive care units: evaluation of a national postmarketing surveillance program. Clin Infect Dis. 1996 Oct; 23(4):779-84.
Score: 0.037
-
The comparative in vitro activity of clinafloxacin and other antimicrobials against vancomycin-susceptible and vancomycin-resistant enterococci. Chemotherapy. 1996 Jul-Aug; 42(4):235-9.
Score: 0.036